Mexico - Delayed Quote • MXN Abbott Laboratories (ABT.MX) Follow 1,845.25 0.00 (0.00%) At close: April 19 at 9:11 AM CST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for ABT.MX 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: ABT.MX View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? It's Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)? Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations U.S. Stocks Slide On Tech Weakness Abbott Labs posts Q1 earnings beat Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges Abbott’s latest Heartmate recall tied to 273 injuries, 14 deaths Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
